Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LANTRONIX INCLTRX · Entity 1667 | Director · President & CEO | September 09, 2026 | September 09, 2026 |
| SIGMA DESIGNS INCSIGM · Entity 164293 | Director | February 25, 2018 | March 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LANTRONIX INC
Report date September 09, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 453,381 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Purchase · Acquired 15,000 · Balance 453,381 F1: This transaction was executed in multiple trades at prices ranging from $5.17 to $5.18. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $5.17 to $5.18. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
SIGMA DESIGNS INC
Report date February 25, 2018 · Filed March 06, 2018
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
Section 16 reporting ended · disclosed 2023-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,587 |
Ending reported balance
After 2023-11-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-17 · Grant · Acquired 772 · Balance 43,856 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Row 2 · 2023-11-17 · Tax withholding · Disposed 1,269 · Balance 42,587 F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2020 Filed Oct 9, 2020 21:11 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 6,740 | $81.66 | $550,388.40 |
DisclosureSEC source: 0001209191-20-054513 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 21:11 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 12,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054513 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,944 F1 · shares: Reflects shares released in connection with the vesting of performance -based market stock units granted on December 13, 2017, December 14, 2018, and October 31, 2019. F2 · balance_after: Includes 252 shares acquired under the issuer's employee stock purchase plan on September 15, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 21:23 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047561 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,814 F1 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of August 17, 2020, until fully vested on August 17, 2023. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 113 | $88.99 | $10,055.87 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 4 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,970 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 250 | $87.88 | $21,970.00 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,083 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 801 | $86.15 | $69,003.03 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,333 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.84 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,107 | $85.35 | $179,826.55 |
DisclosureSEC source: 0001209191-20-046422 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,134 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, and as amended March 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 23:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 865 | $80.02 | $69,217.30 |
DisclosureSEC source: 0001209191-20-044558 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,241 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 39 | $67.14 | $2,618.46 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,106 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,384 | $66.34 | $91,816.22 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,145 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.88, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:58 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,851 | $65.60 | $187,024.17 |
DisclosureSEC source: 0001209191-20-028983 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,529 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,752 | $65.39 | $114,563.28 |
DisclosureSEC source: 0001209191-20-026923 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,380 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. F2 · balance_after: Includes 84 shares acquired under the Issuer's employee stock purchase plan in March 2020. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:48 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 267 | $58.66 | $15,662.22 |
DisclosureSEC source: 0001209191-19-057284 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,048 F1 · kind: The shares were sold pursuant to a 10b5-1 Sales Plan dated February 20, 2019. F2 · balance_after: Includes 139 shares acquired under the Issuer's employee stock purchase plan in November 2019. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 14:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 12,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055080 · doc4.xml · nonDerivative · entry 4 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,176 F4 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of October 31, 2019, until fully vested on October 31, 2022. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 14:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,916 | $42.11 | $80,682.76 |
DisclosureSEC source: 0001209191-19-055080 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,907 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 14:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,082 | $42.11 | $45,563.02 |
DisclosureSEC source: 0001209191-19-055080 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,823 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 14:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055080 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,905 F1 · shares: Reflects shares released on October 31, 2019 in connection with the vesting of performance-based market stock units granted on December 13, 2017 and December 14, 2018. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 22:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,729 | $32.18 | $55,639.22 |
DisclosureSEC source: 0001209191-19-044101 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 21:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 635 | $31.88 | $20,243.80 |
DisclosureSEC source: 0001209191-19-042802 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,729 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. F2 · balance_after: Includes 635 shares acquired under the Issuer's employee stock purchase plan in May 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.